Sequoia China Leads $240M Round In Genomic Big Data Platform WuXi NextCODE

Jillian Yue
September 7, 2017 — 22:06 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Artificial Intelligence big data China chinese genome healthcare investment medicine Neil Shen Outsourcing pharmaceutical Sequoia Sequoia Capital Sequoia Capital China Sequoia CHina Shanghai singapore technology venture capital WuXI AppTec WuXi NextCODE yunfeng capital

Related News:

Saudi Arabia’s FoFs Jada Backs eWTP Arabia Capital’s Second Fund

December 9, 2023 — 02:30

Chinese Charitable Foundations Expand Into Alternative Investments To Enhance Returns

November 30, 2023 — 23:50

Chinese Generative AI Startups Secure Substantial Funding in Race to Replicate OpenAI’s Success

November 13, 2023 — 23:55

Middle Eastern Sovereign Wealth Funds Deepen Investment in China

November 10, 2023 — 23:35

Reports Indicate NVIDIA Tailoring Specialized Chips for China’s Market

November 9, 2023 — 23:26

Kai-Fu Lee’s AI Firm 01.AI Hits Unicorn Status with Alibaba Cloud-Led Funding

November 7, 2023 — 00:55

AI-Driven Pharmaceutical Startups Attract Soaring Investor Interest

November 5, 2023 — 03:24

ByteDance Invested In 52 Deals With Total Deal Value Of $6.4B: TikTok Parent Company’s Investments, M&A, Strategic Deals In One Chart 2019-2022

April 29, 2022 — 01:44

China’s Venture Mega-Deals 2019 to 2022 In One Chart: Can It Last?

April 15, 2022 — 00:30

Franchising and Licensing Asia (FLAsia) 2024